Clearstead Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01K | Sell |
109
-11
| -9% | -$304 | ﹤0.01% | 2237 |
|
|
2025
Q1 | $3.4K | Buy |
120
+8
| +7% | +$227 | ﹤0.01% | 1800 |
|
|
2024
Q4 | $4.66K | Buy |
112
+5
| +5% | +$208 | ﹤0.01% | 1731 |
|
|
2024
Q3 | $7.15K | Sell |
107
-2,438
| -96% | -$163K | ﹤0.01% | 1647 |
|
|
2024
Q2 | $302K | Buy |
2,545
+2,438
| +2,279% | +$290K | 0.01% | 677 |
|
|
2024
Q1 | $13.4K | Sell |
107
-21
| -16% | -$2.64K | ﹤0.01% | 1011 |
|
|
2023
Q4 | $12.7K | Sell |
128
-544
| -81% | -$54.1K | ﹤0.01% | 1019 |
|
|
2023
Q3 | $69.4K | Buy |
672
+324
| +93% | +$33.5K | ﹤0.01% | 819 |
|
|
2023
Q2 | $42.3K | Sell |
348
-1,307
| -79% | -$159K | ﹤0.01% | 762 |
|
|
2023
Q1 | $254K | Buy |
1,655
+905
| +121% | +$139K | 0.02% | 358 |
|
|
2022
Q4 | $135K | Hold |
750
| – | – | 0.01% | 440 |
|
|
2022
Q3 | $89K | Sell |
750
-24
| -3% | -$2.85K | 0.01% | 497 |
|
|
2022
Q2 | $111K | Buy |
774
+420
| +119% | +$60.2K | 0.01% | 482 |
|
|
2022
Q1 | $61K | Hold |
354
| – | – | ﹤0.01% | 643 |
|
|
2021
Q4 | $90K | Buy |
354
+125
| +55% | +$31.8K | 0.01% | 546 |
|
|
2021
Q3 | $88K | Sell |
229
-10
| -4% | -$3.84K | 0.01% | 509 |
|
|
2021
Q2 | $56K | Hold |
239
| – | – | ﹤0.01% | 534 |
|
|
2021
Q1 | $31K | Sell |
239
-6
| -2% | -$778 | ﹤0.01% | 604 |
|
|
2020
Q4 | $26K | Sell |
245
-130
| -35% | -$13.8K | ﹤0.01% | 594 |
|
|
2020
Q3 | $27K | Buy |
375
+330
| +733% | +$23.8K | ﹤0.01% | 553 |
|
|
2020
Q2 | $3K | Buy |
+45
| New | +$3K | ﹤0.01% | 710 |
|